Surgical Innovations Share Price. SUN - Stock Quote, Charts, Trade History, Share Chat, Financials. Surgical Innovations Group Plc

Gold vs US Dollar

Home
Investing
Stocks
UK
LSE
Surgical Innovations Group Plc (SUN)
Surgical Innovations Group Plc (SUN) Share Price

Share Name	Share Symbol	Market	Type	Share ISIN	Share Description
Surgical Innovations Group Plc	LSE:SUN	London	Ordinary Share	GB0004016704	ORD 1P

	Price Change	% Change	Share Price	Shares Traded	Last Trade
	0.00	0.0%	2.20	3,484	07:44:42

Bid Price		Offer Price	High Price	Low Price	Open Price
2.00		2.40	2.20	2.20	2.20

Industry Sector	Turnover (m)	Profit (m)	EPS - Basic	PE Ratio	Market Cap (m)
Surgical,med Instr,apparatus	11.34	0.26	-	-	20.52

Last Trade Time	Trade Type	Trade Size	Trade Price	Currency
14:23:20	O	3,484	2.00	GBX

Related Shares
Smith & Nephew (SN.), Convatec (CTEC), Physiomics (PYC), Deepverge (DVRG)

Surgical Innovations (SUN) Latest News

Surgical Innovations News

Date	Time	Source	Headline
26/5/2023	07:00	UKREG	Surgical Innovations Group PLC Notice of AGM and Posting of Annual Report
25/5/2023	11:11	UKREG	Surgical Innovations Group PLC Director/PDMR Shareholding - Replacement
25/5/2023	07:00	UKREG	Surgical Innovations Group PLC Director/PDMR Shareholding
22/5/2023	12:25	ALNC	IN BRIEF: Surgical Innovations says Glenn becomes chair later this year
22/5/2023	07:00	UKREG	Surgical Innovations Group PLC Directorate changes and board succession..
29/3/2023	11:47	ALNC	IN BRIEF: Surgical Innovations shares up as annual loss narrows
29/3/2023	07:00	UKREG	Surgical Innovations Group PLC Final Results
29/3/2023	06:37	ALNC	GET READY: Next, Essentra, Medica, RM, S4 Capital, at 0700 BST
03/3/2023	07:00	UKREG	Surgical Innovations Group PLC Notice of Results and Investor Presentation
23/1/2023	11:27	ALNC	Surgical Innovations warns NHS strikes may slow new business in 2023

More Surgical Innovations News

Surgical Innovations Investors Surgical Innovations Takeover Rumours

Surgical Innovations (SUN) Discussions and Chat

Surgical Innovations Forums and Chat

Date	Time	Title	Posts
05/6/2023	07:45	(Surging) Surgical Innovations	5,650
31/5/2022	16:14	Surgical Innovations : A New BOD & A New Future	173
05/5/2021	22:25	JERSEY FOOD WAR? OR OFF GRID EXPERIMENT WHEN THE CORNONAL MASS EJECTION HITS?	-
22/5/2020	09:16	WHO IS GOING TO THE BEACH THIS BANK HOLIDAY AND BOOST TOURISM? I AM	-
11/8/2015	10:20	SUNDAY PRESS SHARE TIPS	12

Add a New Thread

Surgical Innovations (SUN) Most Recent Trades

Trade Time	Trade Price	Trade Size	Trade Value	Trade Type
13:23:21	2.00	3,484	69.68	O

View all Surgical Innovations trades in real-time

Surgical Innovations (SUN) Top Chat Posts

Top Posts
Posted at 25/5/2023 07:31 by buywell3 No trades buywell can see over the last few days published reflect this ?? Todays RNS Surgical Innovations Group plc (AIM: SUN), the designer, manufacturer and distributor of innovative medical technology for minimally invasive surgery ("MIS"), was notified on 24 May 2023 that, on 24 May 2023, Janis Glenn (wife of Jonathan Glenn, Non-executive Director) purchased 1,315,482 ordinary shares of 1p each in Surgical Innovations ("Ordinary Shares") at a price of 2.28 pence per share. Surgical Innovations Group PLC 22 May 2023 Surgical Innovations Group Plc Directorate changes and board succession planning Surgical Innovations Group Plc (AIM: SUN), the designer, manufacturer and distributor of innovative technology for minimally invasive surgery, announces the appointment of Jonathan Glenn as Senior Independent Non-executive Director and Chairman-designate of the Company with immediate effect. Jonathan is an experienced board director and chairman, with an excellent track record in the medical device sector. He is currently Non-executive Chairman of Tissue Regenix plc, and was formerly Group CEO of Consort Medical Plc from 2007 to 2020, where he oversaw the £230m acquisition of a European contract development and manufacturing organisation. Jonathan led the business as CEO until its acquisition for £505m in 2020. Jonathan is a member of the Institute of Chartered Accountants in England and Wales. He joins the board in anticipation of the upcoming retirement of Professor Mike McMahon, the founder of the Company, who retires from the board at the Annual General Meeting of the Company expected to take place on 27 June 2023. Following an orderly handover process, Jonathan will succeed Nigel Rogers as Chairman upon announcement of the interim results expected in September 2023. Nigel has indicated his intention to remain on the board until an additional independent non-executive director has been appointed. Chairman of the Company, Nigel Rogers, commented: "It has been my great pleasure to lead the board since my appointment in 2015, and especially to work alongside Prof. Mike McMahon. As part of our planned succession arrangements, we are now delighted to have Jonathan joining us, and look forward to working with him to complete the transition in board composition for the next stage in the Company's evolution." Past Trades May 23, 2023 1.95p 1.81p 1.81p 1.95p 756 May 22, 2023 1.95p 2.05p 2.05p 1.95p 100,000 May 18, 2023 1.95p 1.86p 1.86p 1.95p 382 May 17, 2023 1.95p 2.05p 1.86p 1.95p 49,683 May 16, 2023 1.95p 2.05p 1.86p 1.95p 116,476 May 15, 2023 1.95p 1.86p 1.86p 1.95p 34,500 May 12, 2023 1.95p 2.07p 1.86p 1.95p 210,867 May 11, 2023 1.95p 1.86p 1.86p 1.95p 3,000 May 10, 2023 1.95p 2.07p 1.80p 1.95p 398,351 May 9, 2023 1.95p 2.07p 1.85p 1.95p 17,380 May 5, 2023 1.95p 2.05p 2.05p 1.95p 376,594 May 4, 2023 1.95p 2.05p 2.05p 1.95p 1,267 May 2, 2023 1.95p 2.05p 2.05p 1.95p 4,878 Apr 27, 2023 1.95p 2.05p 1.84p 1.95p 157,461 Apr 26, 2023 1.95p 2.05p 1.84p 1.95p 270,249 Apr 25, 2023 1.95p 1.84p 1.84p 1.95p 51,178 Apr 24, 2023 1.95p 1.84p 1.84p 1.95p 20,000 Apr 21, 2023 1.95p 1.96p 1.82p 1.95p 572,078 Apr 20, 2023 1.95p 1.96p 1.81p 1.95p 191,274 Apr 19, 2023 1.95p 1.96p 1.83p 1.95p 256,282 Apr 18, 2023 1.95p 1.96p 1.87p 1.95p 11,490 Apr 17, 2023 1.95p 1.87p 1.87p 1.95p 125,000 Apr 14, 2023 1.95p 1.97p 1.85p 1.95p 550,000 Apr 12, 2023 1.95p 1.97p 1.97p 1.95p 100,508 Apr 11, 2023 1.95p 1.97p 1.83p 1.95p 82,107 Apr 6, 2023 1.95p 1.97p 1.97p 1.95p 101,221 Apr 4, 2023 1.95p 1.98p 1.98p 1.95p 407 Apr 3, 2023 1.95p 1.98p 1.83p 1.95p 177,465 Mar 31, 2023 1.95p 2.10p 1.80p 1.95p 12,240 Mar 30, 2023 2.10p 2.09p 1.81p 1.95p 1,747,493 Mar 29, 2023 1.95p 2.03p 1.99p 2.05p 549,353 Mar 28, 2023 1.90p 1.99p 1.83p 1.90p 265,245 Mar 27, 2023 1.90p 1.99p 1.83p 1.90p 141,710 Mar 24, 2023 1.90p 1.83p 1.83p 1.90p 73,049 Mar 23, 2023 1.90p 1.99p 1.99p 1.90p 13,467 Mar 22, 2023 1.90p 1.99p 1.83p 1.90p 54,495 Mar 21, 2023 1.90p 1.83p 1.83p 1.90p 83,671 Mar 20, 2023 1.95p 1.99p 1.82p 1.90p 242,833 Mar 17, 2023 1.95p 1.99p 1.90p 1.95p 84,116 Mar 16, 2023 1.95p 1.99p 1.90p 1.95p 51,424 Mar 15, 2023 2.05p 2.05p 1.90p 1.95p 140,000 Mar 14, 2023 2.05p 2.08p 1.91p 2.05p 8,957 Mar 13, 2023 2.05p 2.08p 1.90p 2.05p 36,220 Mar 10, 2023 2.05p 1.92p 1.92p 2.05p 70,000 Mar 9, 2023 2.05p 1.92p 1.92p 2.05p 18,897 Mar 8, 2023 2.05p 2.15p 1.92p 2.05p 6,975 Mar 7, 2023 2.05p 2.15p 1.90p 2.05p 53,746 Mar 6, 2023 2.15p 2.21p 2.00p 2.05p 123,158 Mar 3, 2023 2.15p 2.27p 2.00p 2.15p 679,024 Mar 2, 2023 2.05p 2.29p 2.00p 2.15p 534,776 Read Full Thread Follow Reply
Posted at 30/3/2023 22:33 by buywell3 This is a must listen to video presentation of the Final results IMO htTps://www.youtube.com/watch?v=Z0BERJpSv1g It is buywells understanding that Singer Capital have a EBITDA forecast for SUN at 0.9 Million pounds for 2023 hTtps://www.voxmarkets.co.uk/articles/below-the-radar-surgical-innovations-back-in-good-health-f4d462b/ buywell opines that due to the pent up demand in the US and Japan for 5mm Elite trocars and optical trocars --- plus new orders from India/Germany/other countries due to new market penetration by way of gaining entry to new hospital sales of SI devices on the back of CMR Surgical sales which of course include the 5mm Elite trocar and the optical trocar plus consumables = Add on sales of other existing SI instrumentation and EH offerings plus consumables for both ongoing Due to this buywell is forecasting more than 1M profit for 2023 Double that for 2024 as EU, US and APAC market penetration increases with MDR completed and the new Logi range of graspers and cutters gets added = 2024 profit 2.5 Million pounds Then we have the AMS expected sales of LiquibandFix8 in the USA --- starting soon This alone could be transformational if PMA is given by the US later this financial year Assuming a profit of 1M the P/E for SUN would be 19.12 at todays Mkt Cap At a 2024 2.5M profit the SUN forward P/E would be 7.6 dyor Read Full Thread Follow Reply
Posted at 29/3/2023 22:36 by buywell3 Look at this Final results presentation slides just made available hTtps://www.sigroupplc.com/wp-content/uploads/2023/03/SUN-Investor-presentation-March-2023-Final.pdf Sales look set to accelerate from here into the rest of 2023 Market Environment – USA • YelloPort™ Elite 5mm and Optical trocar expected to have strong impact on US sales this year • Momentum now growing with some early account conversions Market Environment – UK • New account conversions underpinned by sustainability driving growth • Investment in key Sales & Marketing positions enhancing relationships in NHSSC* and private sector • Growth continues into Q1 with sales YTD up on 2022 Market Environment – EU • Strong return to growth, +28% • Sustainability resonates in some key market • Sales & Marketing training has renewed partner focus • New Distributor in Germany beginning to gain traction Market Environment – APAC • Continued growth up 24.6% • Japan underpins sales in the region and registration for 5mm Optical in Q4 will provide further opportunity • India will have positive impact on 2023 Market Environment – ROW • New distribution partner for Canada Market Environment – OEM Business • Strong sales growth up 45% • Collaboration with CMR to develop YP Elite opens opportunity within robotics and new territories • Ongoing supply chain issues disrupted sales to partners in Q1 • Strong order book for Q2 buywell notes --- this has nearly tripled since 2020 and looks set to grow further this year 2023 NPD Projects (under MDR): • Cost down initiatives on YelloPort Elite® range • Extension to Logi® Resposable® range, three new jaw configurations buywell note The extension to the Logi range above is expected to commence Q4 2023 At present it is just one cutter htTps://www.surginno.com/logicut-2-2/ buywell expects various grasper types to be added to the range As buywell has posted 2024 looks set to be a bumper year if AMS LiquibandFix8 is added to the mix with PMA approval for sales to commence in the US --- could be as early at august 2023 --- sales of CMR Surgical Versius robots continues to gain traction = very good for Surgical Innovations Elite 5mm sales + consumables ongoing dyor Read Full Thread Follow Reply
Posted at 06/3/2023 09:54 by gnnmartin Curious, I got an email from the Investigate Alert service this morning telling me that SUN had announced their half year profits. It did not (of course) lead me to an announcement, rather to a suggestion of an announcement that I was not privileged to see. Read Full Thread Follow Reply
Posted at 28/2/2023 14:18 by z1co H2 revenue was really strong and was 10% more than H1.This strong momentum is likely to continue in the current year. The company will provide more info at the time of it's full year results. Share price is still rather subdued but will rebound as the year progresses. Read Full Thread Follow Reply
Posted at 28/2/2023 13:27 by barrenwuffet2 It’s two years post Covid now. SUN should be showing double digit growth alongside all other medical companies Read Full Thread Follow Reply
Posted at 28/2/2023 13:09 by z1co It looks like MM's are a bit short on the stock just 0.5m of buys and they have increased the share price by 6%. With the full year results in a few weeks the shares are likely to rise a lot more. Read Full Thread Follow Reply
Posted at 06/7/2022 08:59 by barrenwuffet2 It looks to me like the company is stuck in a no-mans land, on the one hand, not big enough to develop new products and at the mercy of the NHS and it’s lack of resource and on the other, too expensive to represent good value for an acquirer. This share has not really delivered shareholder value for years and there is nothing in the latest announcement that makes we think that this will change. I’d like to hear Buywells view on the medium term future for SUN after all of his puffing-up. Read Full Thread Follow Reply
Posted at 15/6/2022 06:55 by barrenwuffet2 It looks like the clouds have covered The SUN. A perennial underachiever whatever Buywell says. The NHS is in a big mess. Read Full Thread Follow Reply
Posted at 31/12/2019 11:18 by van zandt May I say the same to most. I feel such excitement coming on!! No. Nothing to do with SUN share price. as ever regards VZ Read Full Thread Follow Reply

Surgical Innovations share price data is direct from the London Stock Exchange

Your Recent History

LSE

SUN

Surgical I..

Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: +44 (0) 203 8794 460 | support@advfn.com

ADVFN UK Investors Hub ADVFN Italy ADVFN Australia ADVFN Brazil

ADVFN Canada ADVFN Germany ADVFN Japan ADVFN Mexico

ADVFN France ADVFN US ADVFN Korea

V: D: 20230607 17:06:25